These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 25063487)
1. A green light for blue light … without single-dose chemotherapy. Griffiths TR; Kockelbergh RC Eur Urol; 2014 Nov; 66(5):872-3. PubMed ID: 25063487 [No Abstract] [Full Text] [Related]
2. Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations. Witjes JA; Babjuk M; Gontero P; Jacqmin D; Karl A; Kruck S; Mariappan P; Palou Redorta J; Stenzl A; van Velthoven R; Zaak D Eur Urol; 2014 Nov; 66(5):863-71. PubMed ID: 25001887 [TBL] [Abstract][Full Text] [Related]
3. [Cost-effectiveness of transurethral resection of the bladder with blue light in patients with non muscle invasive bladder cancer in France]. Rouprêt M; Malavaud B; Molinier L; Leleu H; Blachier M; Marteau F Prog Urol; 2015 Apr; 25(5):256-64. PubMed ID: 25605343 [TBL] [Abstract][Full Text] [Related]
4. Fluorescence-guided transurethral resection of bladder cancer using hexaminolevulinate: analysis of health economic impact in Sweden. Malmström PU; Hedelin H; Thomas YK; Thompson GJ; Durrant H; Furniss J Scand J Urol Nephrol; 2009; 43(3):192-8. PubMed ID: 19330681 [TBL] [Abstract][Full Text] [Related]
5. Budget impact of incorporating one instillation of hexaminolevulinate hydrochloride blue-light cytoscopy in transurethral bladder tumour resection for patients with non-muscle-invasive bladder cancer in Sweden. Rose JB; Armstrong S; Hermann GG; Kjellberg J; Malmström PU BJU Int; 2016 Jun; 117(6B):E102-13. PubMed ID: 26305667 [TBL] [Abstract][Full Text] [Related]
6. Surgical advances in bladder cancer: at what cost? Johnson DC; Greene PS; Nielsen ME Urol Clin North Am; 2015 May; 42(2):235-52, ix. PubMed ID: 25882565 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of fluorescent cystoscopy for noninvasive papillary tumors: con. Lotan Y J Urol; 2012 May; 187(5):1538-9. PubMed ID: 22606696 [No Abstract] [Full Text] [Related]
8. Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature. Rink M; Babjuk M; Catto JW; Jichlinski P; Shariat SF; Stenzl A; Stepp H; Zaak D; Witjes JA Eur Urol; 2013 Oct; 64(4):624-38. PubMed ID: 23906669 [TBL] [Abstract][Full Text] [Related]
9. Blue Light Cystoscopy Should be Used Routinely for Bladder Cancer Detection: Pro. Steinberg G J Urol; 2016 Jun; 195(6):1652-3. PubMed ID: 26995542 [No Abstract] [Full Text] [Related]
10. The cost-effectiveness of blue light cystoscopy in bladder cancer detection: United States projections based on clinical data showing 4.5 years of follow up after a single hexaminolevulinate hydrochloride instillation. Garfield SS; Gavaghan MB; Armstrong SO; Jones JS Can J Urol; 2013 Apr; 20(2):6682-9. PubMed ID: 23587507 [TBL] [Abstract][Full Text] [Related]
11. The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer. Witjes JA; Douglass J Nat Clin Pract Urol; 2007 Oct; 4(10):542-9. PubMed ID: 17921969 [TBL] [Abstract][Full Text] [Related]
12. Hexaminolevulinate hydrochloride blue-light flexible cystoscopy in the detection and follow-up of nonmuscle-invasive bladder cancer: cost consequences during outpatient surveillance in Sweden. Dansk V; Malmström PU; Bläckberg M; Malmenäs M Future Oncol; 2016; 12(8):1025-38. PubMed ID: 26975197 [TBL] [Abstract][Full Text] [Related]
13. [Calculating the price of a new diagnostic or therapeutic option. Example of transurethral resection of bladder tumors using photodynamic diagnostics with hexaminolevulinic acid]. Burger M; Petschl S; Volkmer BG Urologe A; 2008 Sep; 47(9):1239-44. PubMed ID: 18679653 [TBL] [Abstract][Full Text] [Related]
14. Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations. Witjes JA; Redorta JP; Jacqmin D; Sofras F; Malmström PU; Riedl C; Jocham D; Conti G; Montorsi F; Arentsen HC; Zaak D; Mostafid AH; Babjuk M Eur Urol; 2010 Apr; 57(4):607-14. PubMed ID: 20116164 [TBL] [Abstract][Full Text] [Related]
15. Blue light cystoscopy for detection and treatment of non-muscle invasive bladder cancer. Mark JR; Gelpi-Hammerschmidt F; Trabulsi EJ; Gomella LG Can J Urol; 2012 Apr; 19(2):6227-31. PubMed ID: 22512972 [TBL] [Abstract][Full Text] [Related]
16. Blue-sky thinking about blue-light cystoscopy. Thomas K; O'Brien T BJU Int; 2009 Oct; 104(7):887-9. PubMed ID: 19583718 [No Abstract] [Full Text] [Related]